Keita Fukuyama

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 4

Top Topics

Health Insurance

Respiratory Syndrome Coronavirus

Top Venues

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Keita Fukuyama, Yukiko Mori, Hiroaki Ueshima, Shiho Ito, Masaki Tanabe, Tomohiro Kuroda
Medical resource usage for COVID-19 evaluated using the National Database of Health Insurance Claims and Specific Health Checkups of Japan. PloS one 19 (5) (2024)
Keita Fukuyama, Yukiko Mori, Hiroaki Ueshima, Shiho Ito, Masaki Tanabe, Tomohiro Kuroda
Medical resource usage for COVID-19 evaluated using the National Database of Health Insurance Claims and Specific Health Checkups of Japan. PloS one 19 (5) (2024)
Keita Fukuyama, Masataka Asagiri, Masahiro Sugimoto, Hiraki Tsushima, Satoru Seo, Kojiro Taura, Shinji Uemoto, Keiko Iwaisako
Gene expression profiles of liver cancer cell lines reveal two hepatocyte-like and fibroblast-like clusters. PloS one 16 (2) (2021)
Shinya Ohashi, Osamu Kikuchi, Yukie Nakai, Tomomi Ida, Tomoki Saito, Yuki Kondo, Yoshihiro Yamamoto, Yosuke Mitani, Trang H Nguyen Vu, Keita Fukuyama, Hiroshi Tsukihara, Norihiko Suzuki, Manabu Muto
Synthetic Lethality with Trifluridine/Tipiracil and Checkpoint Kinase 1 Inhibitor for Esophageal Squamous Cell Carcinoma. Molecular cancer therapeutics 19 (6) (2020)